Lower risk for Down syndrome associated with longer oral contraceptive use: A case-control study of women of advanced maternal age presenting for prenatal diagnosis

Contraception

Volumn 87, Issue 4, 2013, Pages 455-458

  Nagy, Gyula Richárd ^a   Gyorffy, Balázs ^b   Nagy, Bálint ^a   Rigó Jr , János ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Advanced maternal age; Down syndrome; Mosaicism; Oral contraceptive pill; Risk

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AMNIOCENTESIS; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GENETIC ANALYSIS; HUMAN; MATERNAL AGE; ORAL CONTRACEPTION; OVULATION; PREGNANCY; PRENATAL DIAGNOSIS; REPRODUCTION; TRISOMY 13; TRISOMY 18; TRISOMY 21;

ADULT; AMNIOCENTESIS; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL, HORMONAL; DOWN SYNDROME; FEMALE; HUMANS; HUNGARY; MATERNAL AGE; MOSAICISM; OVULATION; PREGNANCY; TRISOMY;

EID: 84875274690     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.08.040     Document Type: Article

References (12)

1. S. Ghosh, E. Feingold, and S.K. Dey Etiology of Down syndrome: evidence for consistent association among altered meiotic recombination, nondisjunction and maternal age across populations Am J Med Genet A 149 2009 1415 1420
2. T.R. Oliver, E. Feingold, and K. Yu New insights into human nondisjunction of chromosome 21 in oocytes PLoS Genet 4 2008 e1000033
3. E.G. Allen, S.B. Freeman, and C. Druschel Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects Hum Genet 125 2009 41 52
4. Hultén MA, Patel SD, Tankimanova M, et al. On the origin of trisomy 21 Down syndrome. Mol Cytogenet 2008;18:1:21.
5. M.A. Hultén, S. Patel, J. Jonasson, and E. Iwarsson On the origin of the maternal age effect in trisomy 21 Down syndrome: the oocyte mosaicism selection model Reproduction 139 2010 1 9
6. A.L. Barlow, C. Tease, and M.A. Hultén Meiotic chromosome pairing in fetal oocytes of trisomy 21 human females Cytogenet Genome Res 96 2002 45 51
7. I.Y. Iourov, S.G. Vorsanova, and Y.B. Yurov Chromosomal mosaicism goes global Molec Cytogenet 1 2008 26
8. Q. Yang, S.L. Sherman, and T.J. Hassold Risk factors for trisomy 21: maternal cigarette smoking and oral contraceptive use in a population-based case-control study Genet Med 1 1999 80 88
9. M.L. Martínez-Frías, E. Bermejo, E. Rodríguez- Pinilla, and L. Prieto Periconceptional exposure to contraceptive pills and risk for Down syndrome J Perinat 21 2001 288 292
10. S. Ghosh, C.S. Hong, and E. Feingold Epidemiology of Down syndrome: new insight into the multidimensional interactions among genetic and environmental risk factors in the oocyte Am J Epidemiol 174 2001 1009 1016
11. S.B. Freeman, Q. Yang, K. Allran, L.F. Taft, and S.L. Sherman Women with a reduced ovarian complement may have an increased risk for a child with Down syndrome Am J Hum Genet 66 2000 1680 1683
12. J.H. Ford, and L. MacCormac Pregnancy and lifestyle study: the long-term use of the contraceptive pill and the risk of age-related miscarriage Hum Reprod 10 1995 1397 1402